| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
3 companies
Jeffs Roger is a Chief Executive Officer at LQDA, with reported holdings spanning 3 companies. Recent filings cover 7 purchases and 31 sales. Those positions are worth an estimated $114.4M at current prices.
Our model assigns Jeffs Roger a middling insider score of 64/100, based on 25 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -18.2%.
Jeffs Roger's largest disclosed position is in LQDA as Chief Executive Officer, worth about $102.0M. The recent filings there lean toward selling, a net 146,072 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | LQDA Liquidia Corp | Chief Executive Officer | Buy | 139,665 | $7.16 | $1,000,001.40 | +27.9% | +102.1% | +49.8% | |
| Sep 6, 2022 | LQDA Liquidia Corp | Chief Executive Officer | Buy | 43,820 | $5.57 | $243,989.76 | +37.8% | -7.8% | +21.9% | |
| Aug 31, 2022 | LQDA Liquidia Corp | Chief Executive Officer | Buy | 993 | $4.90 | $4,870.17 | +0.9% | -16.1% | +19.1% | |
| May 24, 2022 | LQDA Liquidia Corp | Chief Executive Officer | Buy | 28,000 | $3.53 | $98,812.00 | +150.6% | +126.1% | +154.6% | |
| Nov 19, 2021 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 3,950 | $37.30 | $147,350.01 | +3.4% | -15.1% | +56.9% | |
| Apr 13, 2021 | LQDA Liquidia Corp | Director | Buy | 99,206 | $2.52 | $249,999.12 | +793.6% | +3.9% | +105.1% | |
| Sep 7, 2018 | SGMO Sangamo Therapeutics, Inc | Director | Buy | 7,408 | $13.56 | $100,486.56 | +296.3% | - | - |